| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |